Metabolic Profiling Identified a Novel Biomarker Panel for Metabolic Syndrome-Positive Hepatocellular Cancer

Metabolic syndrome (MetS) is an independent risk factor for hepatocellular cancer (HCC). Currently, there is no highly sensitive and specific biomarkers for HCC surveillance in MetS population. Metabolomics has been reported as a powerful technology for biomarker discovery. In the present study, we...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Lin-Lin, Han, Yi, Wang, Yuanxiao, Pei, Lin, Yue, Zhihong, Qin, Li, Liu, Boyu, Cui, Jingwen, Jia, Mei, Wang, Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8826723/
https://www.ncbi.nlm.nih.gov/pubmed/35154012
http://dx.doi.org/10.3389/fendo.2021.816748

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8826723/
https://www.ncbi.nlm.nih.gov/pubmed/35154012
http://dx.doi.org/10.3389/fendo.2021.816748

Ejemplares similares